PMS34 TALTZ® (IXEKIZUMAB) FOR TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES: A BUDGET IMPACT ANALYSIS
May 1, 2020, 00:00 AM
10.1016/j.jval.2020.04.721
https://www.valueinhealthjournal.com/article/S1098-3015(20)30909-8/fulltext
Section Title :
Section Order :
10619
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30909-8&doi=10.1016/j.jval.2020.04.721